The invention relates to a method for alleviating the inhibition of neurite outgrowth from a
neurone, wherein said neurone comprises a Nogo receptor, said method comprising contact …

514/45 (57) ABSTRACT The present invention is based on the discovery that Suppress ing
the activity of the Nogo receptor (NgR) alone does not result in extensive axon regeneration …

Related US Application Data 435/254.2: 435/69.1; 435/375; 506/9; 435/348;(60) Division of
application No. 12/693,940, filed on Jan. 435/325; 435/354; 435/353; 435/363; 435/366; 26 …

Related US Application Data 514/12: 435/7.21 (60) Division of application No. 09/972,599,
filed on Oct. 6, 2001, now Pat. No. 7,119,165, which is a continua-(57) ABSTRACT sing RS …

C07K 6/28(2006.01)(21) Appl. No.: 14/088,158 C07K 4/705(2006.01)(52) US Cl.(22) Filed:
Nov. 22, 2013 CPC............... C07K 16/28 (2013.01); C07K 14/705 (2013.01) Related US …

Disclosed are NgR proteins and biologically active Nogo (ligand) protein fragments. Also
disclosed are compositions and methods for modulating the expression or activity of the …

Disclosed are Nogo receptor proteins and biologically active Nogo (ligand) protein
fragments. Also disclosed are com positions and methods for modulating the expression or …

Disclosed are NgR proteins and biologically active Nogo (ligand) protein fragments. Also
disclosed are compositions and methods for modulating the expression or activity of the …

Disclosed are NgR proteins and biologically active Nogo (ligand) protein fragments. Also
disclosed are compositions and methods for modulating the expression or activity of the …

US20080045926A1 - Treatment of Conditions Involving Dopaminergic Neuronal Degeneration
Using Nogo Receptor Antagonists - Google Patents US20080045926A1 - Treatment of …